Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Free Cash Flow (2019 - 2025)

Historic Free Cash Flow for BioScience Health Innovations (BHIC) over the last 7 years, with Q3 2025 value amounting to -$340445.0.

  • BioScience Health Innovations' Free Cash Flow fell 75178.14% to -$340445.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $222569.0, marking a year-over-year increase of 120646.28%. This contributed to the annual value of $23188.0 for FY2024, which is 10753.24% up from last year.
  • BioScience Health Innovations' Free Cash Flow amounted to -$340445.0 in Q3 2025, which was down 75178.14% from $285010.0 recorded in Q2 2025.
  • BioScience Health Innovations' 5-year Free Cash Flow high stood at $328309.0 for Q1 2025, and its period low was -$340445.0 during Q3 2025.
  • Moreover, its 5-year median value for Free Cash Flow was -$25027.0 (2022), whereas its average is -$5851.7.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 92093.43% in 2021, then soared by 78340.76% in 2025.
  • BioScience Health Innovations' Free Cash Flow (Quarter) stood at -$5901.0 in 2021, then plummeted by 372.97% to -$27910.0 in 2022, then tumbled by 102.28% to -$56457.0 in 2023, then grew by 10.9% to -$50305.0 in 2024, then plummeted by 576.76% to -$340445.0 in 2025.
  • Its last three reported values are -$340445.0 in Q3 2025, $285010.0 for Q2 2025, and $328309.0 during Q1 2025.